209 related articles for article (PubMed ID: 31227582)
1. Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.
Cho J; Scragg R; Pandol SJ; Goodarzi MO; Petrov MS
Diabetes Care; 2019 Sep; 42(9):1675-1683. PubMed ID: 31227582
[TBL] [Abstract][Full Text] [Related]
2. Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry.
Cho J; Scragg R; Petrov MS
Diabetes Care; 2020 Sep; 43(9):2106-2112. PubMed ID: 32616613
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide cohort study.
Davidsen L; Jensen MH; Cook ME; Vestergaard P; Knop FK; Drewes AM; Olesen SS
Eur J Endocrinol; 2024 Jan; 190(1):44-53. PubMed ID: 38134412
[TBL] [Abstract][Full Text] [Related]
4. Risk of Mortality and Hospitalization After Post-Pancreatitis Diabetes Mellitus vs Type 2 Diabetes Mellitus: A Population-Based Matched Cohort Study.
Cho J; Scragg R; Petrov MS
Am J Gastroenterol; 2019 May; 114(5):804-812. PubMed ID: 31021833
[TBL] [Abstract][Full Text] [Related]
5. Risk of cause-specific death, its sex and age differences, and life expectancy in post-pancreatitis diabetes mellitus.
Cho J; Pandol SJ; Petrov MS
Acta Diabetol; 2021 Jun; 58(6):797-807. PubMed ID: 33590329
[TBL] [Abstract][Full Text] [Related]
6. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
7. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
Bowker SL; Majumdar SR; Veugelers P; Johnson JA
Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
[TBL] [Abstract][Full Text] [Related]
8. Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality in Postpancreatitis Diabetes Mellitus Versus Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
Olesen SS; Viggers R; Drewes AM; Vestergaard P; Jensen MH
Diabetes Care; 2022 Jun; 45(6):1326-1334. PubMed ID: 35312752
[TBL] [Abstract][Full Text] [Related]
9. Glucose-Lowering Therapy in Patients With Postpancreatitis Diabetes Mellitus: A Nationwide Population-Based Cohort Study.
Viggers R; Jensen MH; Laursen HVB; Drewes AM; Vestergaard P; Olesen SS
Diabetes Care; 2021 Sep; 44(9):2045-2052. PubMed ID: 34362812
[TBL] [Abstract][Full Text] [Related]
10. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
11. No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study.
Frouws MA; Sibinga Mulder BG; Bastiaannet E; Zanders MMJ; van Herk-Sukel MPP; de Leede EM; Bonsing BA; Mieog JSD; Van de Velde CJH; Liefers GJ
Medicine (Baltimore); 2017 Mar; 96(10):e6229. PubMed ID: 28272215
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical characteristics of postpancreatitis diabetes mellitus: A cross-sectional study from the Danish nationwide DD2 cohort.
Olesen SS; Svane HML; Nicolaisen SK; Kristensen JK; Drewes AM; Brandslund I; Beck-Nielsen H; Nielsen JS; Thomsen RW
J Diabetes; 2021 Dec; 13(12):960-974. PubMed ID: 34240829
[TBL] [Abstract][Full Text] [Related]
13. Exocrine Pancreatic Dysfunction Increases the Risk of New-Onset Diabetes Mellitus: Results of a Nationwide Cohort Study.
Cho J; Scragg R; Pandol SJ; Petrov MS
Clin Transl Sci; 2021 Jan; 14(1):170-178. PubMed ID: 32692901
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
[TBL] [Abstract][Full Text] [Related]
16. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
17. The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea.
Lee DY; Yu JH; Park S; Han K; Kim NH; Yoo HJ; Choi KM; Baik SH; Kim NH; Seo JA
Sci Rep; 2018 Jun; 8(1):9719. PubMed ID: 29946194
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Gout and Diabetes Mellitus after Acute Pancreatitis: A Nationwide Cohort Study.
Cho J; Dalbeth N; Petrov MS
J Rheumatol; 2020 Jun; 47(6):917-923. PubMed ID: 31615915
[TBL] [Abstract][Full Text] [Related]
20. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
